Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA: 600222)

Henan Taloph Pharmaceutical Stock Co.,Ltd Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	369.46	196.67	311.38	380.55	487.32	398.16
Trading Asset Securities	28.29	153.3	74.96	285.67	207.46	176.4
Cash & Short-Term Investments	397.75	349.97	386.34	666.22	694.78	574.56
Cash Growth	62.93%	-9.42%	-42.01%	-4.11%	20.92%	-14.26%
Accounts Receivable	1,057	1,056	1,038	744.71	689.25	628.24
Other Receivables	51.71	44.01	51.15	56.44	78.65	183.73
Receivables	1,109	1,100	1,089	801.15	767.89	811.97
Inventory	519.48	455.5	450.49	381.85	348.14	299.95
Other Current Assets	124.28	87.88	105.03	94.49	71.56	73.17
Total Current Assets	2,150	1,993	2,031	1,944	1,882	1,760
Property, Plant & Equipment	491.38	529.65	551.13	539.58	494.09	448.82
Long-Term Investments	545.15	520.38	490.93	825.63	533.76	248.16
Goodwill	286.49	286.49	286.49	286.49	286.49	286.49
Other Intangible Assets	52.38	52.5	48.11	53.1	57.54	62.26
Long-Term Deferred Tax Assets	101.99	94.24	95.38	52.4	47.16	43.63
Long-Term Deferred Charges	45.52	49.81	54.23	35.81	32.98	31.9
Other Long-Term Assets	51.44	50.71	49.08	47.05	54.99	50.32
Total Assets	3,725	3,577	3,607	3,784	3,389	2,931
Accounts Payable	478.91	470.29	548.89	355.65	211.71	142.78
Accrued Expenses	8.63	24.27	32.22	22.45	20.56	25.36
Short-Term Debt	600.34	381.84	404.87	973.58	750.22	574.9
Current Portion of Long-Term Debt	304.7	89.29	4.22	158.74	406.21	29
Current Portion of Leases	-	35.82	26.89	-	-	-
Current Income Taxes Payable	10.45	2.53	21.86	3.7	2.98	4.67
Current Unearned Revenue	7.58	11.62	88.26	49.47	61.27	-
Other Current Liabilities	591.26	634.5	598.82	86.09	50.94	182.38
Total Current Liabilities	2,002	1,650	1,726	1,650	1,504	959.09
Long-Term Debt	6.8	183.8	192.8	20.37	136.38	541.3
Long-Term Leases	68.62	89.29	37.14	72.06	31.6	-
Long-Term Unearned Revenue	2.87	3.26	1.71	-	-	-
Long-Term Deferred Tax Liabilities	24.46	25.36	33.26	132.42	56.96	2.95
Other Long-Term Liabilities	-	1.62	1.62	131.62	130	-
Total Liabilities	2,105	1,953	1,993	2,006	1,859	1,503
Common Stock	573.89	573.89	573.89	573.89	573.89	573.89
Additional Paid-In Capital	675.17	675.17	675.17	588.14	588.14	720.48
Retained Earnings	299.92	281.01	237.46	232.15	235.16	205.92
Treasury Stock	-101.01	-79.72	-37.66	-48.7	-98.47	-125.28
Comprehensive Income & Other	122.37	128.15	121.56	315.04	154.7	-
Total Common Equity	1,570	1,578	1,570	1,661	1,453	1,375
Minority Interest	49.59	44.89	43.62	117.13	77.16	52.9
Shareholders' Equity	1,620	1,623	1,614	1,778	1,531	1,428
Total Liabilities & Equity	3,725	3,577	3,607	3,784	3,389	2,931
Total Debt	980.46	780.03	665.92	1,225	1,324	1,145
Net Cash (Debt)	-582.7	-430.07	-279.58	-558.53	-629.62	-570.64
Net Cash Per Share	-1.05	-0.76	-0.50	-1.00	-1.15	-1.03
Filing Date Shares Outstanding	554.67	559.36	566.69	563.04	545.98	545.98
Total Common Shares Outstanding	554.67	559.36	566.69	563.04	545.98	545.98
Working Capital	148.33	342.93	305.21	294.03	378.49	800.57
Book Value Per Share	2.83	2.82	2.77	2.95	2.66	2.52
Tangible Book Value	1,231	1,239	1,236	1,321	1,109	1,026
Tangible Book Value Per Share	2.22	2.22	2.18	2.35	2.03	1.88
Buildings	-	543.26	534.9	520.76	516.81	466.61
Machinery	-	341.92	316.19	281.14	247.95	220.14
Construction In Progress	-	28.9	31.1	33.02	24.31	26.06

Source: S&P Capital IQ. Standard template. Financial Sources.